Evaluation of first trimester serum soluble endothelial cell-specific tyrosine kinase receptor in normal and affected pregnancies.

about

Evaluation of first trimester serum soluble endothelial cell-specific tyrosine kinase receptor in normal and affected pregnancies.

Item

http://www.wikidata.org/entity/Q54319367

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Evaluation of first trimester ...... rmal and affected pregnancies.

@en

Evaluation of first trimester ...... rmal and affected pregnancies.

@nl

type

Item

label

Evaluation of first trimester ...... rmal and affected pregnancies.

@en

Evaluation of first trimester ...... rmal and affected pregnancies.

@nl

prefLabel

Evaluation of first trimester ...... rmal and affected pregnancies.

@en

Evaluation of first trimester ...... rmal and affected pregnancies.

@nl

P1476

Evaluation of first trimester ...... rmal and affected pregnancies.

@en

P2093

Anthony W Ashton

http://www.w3.org/2001/XMLSchema#string

Christine L Roberts

http://www.w3.org/2001/XMLSchema#string

Cyrille Guilbert

http://www.w3.org/2001/XMLSchema#string

Jonathan M Morris

http://www.w3.org/2001/XMLSchema#string

Vitomir Tasevski

http://www.w3.org/2001/XMLSchema#string

P2860

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data.

Multiple Imputation for Multivariate Missing-Data Problems: A Data Analyst's Perspective.

Using hospital discharge data for determining neonatal morbidity and mortality: a validation study.

The accuracy of reporting of the hypertensive disorders of pregnancy in population health data.

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.

Angiogenesis modulates adipogenesis and obesity.

Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling.

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

P304

1815-1821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2014.969233

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francisco J Schneuer

Natasha Nassar

P577

2014-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25260125

http://www.w3.org/2001/XMLSchema#string